Alzheimer's and Neurodegeneration
Our team aims to make discoveries in the field of Alzheimer’s and neurodegenerative disease, using applied research that spans across community settings to aged care, employing co-design and implementation science frameworks to deliver maximal discovery and translation opportunities for future care.
Alzheimer’s is the most common cause of dementia and is a neurodegenerative disease. Dementia is the second leading cause of death for all Australians.
Pictured from left to right; Professor Sharon Naismith and Dr Eleanor Drummond
Our Current Projects:
Initially, the team will focus on discovery of how changes in blood can yield new mechanistic insights into cognitive decline and neuroimaging biomarkers, and how these may change in response to major stressors (e.g. surgery), modifiable dementia risk factors (alcohol, blood pressure, sleep, depression), and in novel therapies targeting amyloid, tau or neuroinflammation. The team will conduct innovative work within clinical cohorts derived from the Brain and Mind Centre’s Healthy Brain Ageing Program, as well as from large existing databanks such as the UK biobank.
We work to assess, prevent and treat cognitive decline, dementia, Alzheimer’s disease and depression in older adults.
Team Leadership
Team Members
Associate Professor Greg Sutherland
Associate Professor, Fiona Kumfor
Associate Professor Ramon Landin-Romero
Dr Zac Chatterton
Dr Tomas Kavanagh
Early and Mid-Career Researchers
Dr Tomas Kavanagh
Dr Shawn Kong
Dr Zoe Schrire
Dr Ka Ka Ting
Dr Zac Chatterton
Dr Nathan Cross
HDR Students
Mr Hamish Mundell